Compare Humana Inc (HUM) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Toyota Motor Corp — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Toyota Motor Corp trades at $185.3 (market cap $217.38B). The key difference: Toyota Motor Corp is far larger — about 4.7× Humana Inc's market cap, and Toyota Motor Corp pays the higher dividend (3.37%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Toyota Motor Corp for 116 Days on average.
| HUM | TM | |
|---|---|---|
Market Cap | $46.49B | $217.38B |
Volume | 2,567,704 | 291,250 |
Sector | Health | Consumer Cyclical |
52-Week High | $431.03 | $248.29 |
52-Week Low | $163.67 | $166.50 |
Typical Hold Time | 51 Days | 116 Days |
Enterprise Value | $53.84B | $410.96B |
Dividend Yield | 0.91% | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
Toyota Motor (TM) trades at $186.00, up 1.69% today, with a bearish technical signal but strong fundamentals. The stock shows attractive valuation ratios, including a P/E of 8.38 and P/B of 0.93, and has beaten EPS estimates in recent quarters. Recent news highlights U.S. sales growth and electrification efforts, though production declines in China and floods in Thailand pose challenges. Cash flow turned negative in 2025 but is projected to rebound in 2026.
TM presents a value opportunity with low multiples and consistent profitability, but near-term headwinds from global sales softness and supply chain disruptions warrant caution. Analyst consensus is mixed, with 37.5% buy ratings versus 62.5% hold, reflecting balanced optimism and patience. The stock's outlook hinges on execution in electrification and recovery in key markets like China.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
